Jortveit Jarle, Myhre Peder L, Berge Kristian, Halvorsen Sigrun
Department of Cardiology, Sorlandet Hospital, Arendal, Norway.
Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
ESC Heart Fail. 2025 Aug;12(4):2528-2539. doi: 10.1002/ehf2.15265. Epub 2025 Mar 18.
Left ventricular (LV) dysfunction following acute myocardial infarction (AMI) is common even in the absence of signs and symptoms of heart failure (HF). Recent trials of patients with LV dysfunction post-AMI have demonstrated low event rates during follow-up. We aimed to assess the real-world prevalence and outcomes post-AMI, stratified by LV ejection fraction (LVEF) and the presence or absence of HF symptoms.
Cohort study of patients with AMI registered in the Norwegian Myocardial Infarction Registry 2013-2022. Outcomes were short- and long-term all-cause mortality. Mortality was assessed by Kaplan-Meier survival curves, Life Table and multivariable Cox regression models.
Among 70 809 AMI patients (mean age 68.1 ± 12.9 years, 31% female), preserved (≥50%), mildly reduced (41%-49%) and reduced (≤40%) LVEF were present in 63.5%, 23.2% and 13.3%, respectively. Symptomatic HF was present in 3.3%, 28.1% and 63.2% of patients with preserved, mildly reduced and reduced LVEF. For each LVEF category, 1-year cumulative mortality rate from discharge was 3.9%, 7.8% and 17.8% for asymptomatic, and 16.2%, 13.7% and 20.2% for symptomatic patients, respectively. Symptomatic patients discharged alive had higher risk of mortality than asymptomatic: adjusted hazard ratio 1.85 (1.70-2.02) for preserved LVEF, 1.33 (1.25-1.41) for mildly reduced LVEF and 1.15 (1.06-1.24) for reduced LVEF.
Reduced LVEF in the acute phase of AMI was associated with up to 20% 1-year mortality after discharge, substantially higher than in recent post-MI trials. Symptoms of HF during the index hospitalization were associated with worse outcomes in patients with preserved LVEF but contributed little additive risk for patients with reduced LVEF.
即使在没有心力衰竭(HF)体征和症状的情况下,急性心肌梗死(AMI)后左心室(LV)功能障碍也很常见。近期针对AMI后左心室功能障碍患者的试验显示随访期间事件发生率较低。我们旨在评估AMI后的实际患病率和预后,根据左心室射血分数(LVEF)以及是否存在HF症状进行分层。
对2013年至2022年在挪威心肌梗死登记处登记的AMI患者进行队列研究。结局指标为短期和长期全因死亡率。死亡率通过Kaplan-Meier生存曲线、生命表和多变量Cox回归模型进行评估。
在70809例AMI患者中(平均年龄68.1±12.9岁,31%为女性),LVEF保留(≥50%)、轻度降低(41%-49%)和降低(≤40%)的患者分别占63.5%、23.2%和13.3%。有症状HF的患者在LVEF保留、轻度降低和降低的患者中分别占3.3%、28.1%和63.2%。对于每个LVEF类别,出院后1年无症状患者的累积死亡率分别为3.9%、7.8%和17.8%,有症状患者分别为16.2%、13.7%和20.2%。存活出院的有症状患者的死亡风险高于无症状患者:LVEF保留时调整后的风险比为1.85(1.70-2.02),LVEF轻度降低时为1.33(1.25-1.41),LVEF降低时为1.15(1.06-1.24)。
AMI急性期LVEF降低与出院后高达20%的1年死亡率相关,显著高于近期心肌梗死后试验中的死亡率。指数住院期间HF症状与LVEF保留患者的预后较差相关,但对LVEF降低患者几乎没有额外风险。